This year, the National Cannabis Bar Association’s Second Annual Cannabis Law Institute will take place on September 7 and 8 in Washington, D.C. at the George Washington University Law School.
Featuring some of the nation’s leading attorneys, academics, and politicians, this event will convene the best minds and visionaries working in the cannabis industry and reform movement for two days of panels and discussion. Programming is focused on education for attorneys, and you can receive 11+ CLE credits for select jurisdictions. Evenings will feature networking events.
We’re excited to announce that MPP’s Deputy Director Matt Schweich will be moderating the panel discussion on Federalism & States’ Rights, which will also include MPP’s Director of Federal Policies, Don Murphy.
You’re invited to attend by registering here. Use the code “friendsofncba” to receive $200 off the full ticket price, and if you are a member of NCBA, you get an additional $100 off.
With over 60 speakers and panelists from organizations like the Brookings Institution, the National Cannabis Industry Association, Americans for Safe Access, and leading cannabis law firm Vicente Sederberg, the conference will address the most challenging areas of law as they relate to the cannabis industry, including banking, tax, finance, intellectual property, labor and employment, corporate governance, and more. Congressmen Earl Blumenauer of Oregon and David Joyce of Ohio will also be in attendance as part of the keynote conversation on Friday morning.
If you live in the D.C. metro area, you don’t want to miss this important event. We hope to see you there!
Early this week, the Brookings Institution released a report titled 'Ending the U.S. government's war on medical marijuana research', which analyzes the ways in which the federal government hinders effective research, and how these policies could be changed.
The federal government is stifling medical research in a rapidly transforming area of public policy that has consequences for public health and public safety. As medical marijuana becomes increasingly accessible in state-regulated, legal markets, and as others self-medicate in jurisdictions that do not allow the medical use of cannabis, it is increasingly important that the scientific community conduct research on this substance. However, statutory, regulatory, bureaucratic, and cultural barriers have paralyzed science and threatened the integrity of research freedom in this area. It is time for the federal government to recognize the serious public policy risks born from limited medical, public health, and pharmaceutical research into cannabis and its use.
You can read the full report here.
On Monday, respected policy think tank The Brookings Institution published a paper analyzing Washington's implementation of the law passed in 2012 to regulate marijuana similarly to alcohol. The results: the state is doing well and is actively trying to learn from the process. The results could have far-reaching implications for marijuana policy reform in other states.
Brookings’ Philip Wallach interviewed advocates, researchers, and government policymakers in Washington to learn about the state’s novel approach. In this report, he highlights several noteworthy features:
- Building a funding source for research directly into the law: a portion of the excise tax revenues from marijuana sales will fund research on the reform’s effects and on how its social costs can be effectively mitigated.
- Bringing to bear many perspectives on legalization by coordinating research efforts across multiple state agencies, including the Department of Social and Health Services, the Department of Health, and the Liquor Control Board.
- Mandating a cost-benefit analysis by the state’s in-house think tank, which will be nearly unprecedented in its scope and duration.
Wallach makes a number of suggestions to ensure that Washington’s knowledge experiment can be made to work, including:
- Ensure political independence for researchers, both by pressuring politicians to allow them to do their work and by encouraging the researchers themselves to refrain from making political recommendations
- Gather and translate research into forms usable by policymakers
- Counter misinformation with claims of confident uncertainty
- Have realistic expectations about the timeline for empirical learning, which means cultivating patience over the next few years
- Specify which reliable metrics would indicate success or failure of legalization